Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2018
Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited SettingsKevin R Robertson, Hongyu Jiang, Johnstone Kumwenda, et al.The New England Journal of Medicine|October 21, 2011
Timing of antiretroviral therapy for HIV-1 infection and tuberculosisDiane V Havlir, Michelle A Kendall, Prudence Ive, et al.Journal of Neurovirology|May 27, 2010
NeuroAIDS in AfricaKevin Robertson, Jeff Liner, James Hakim, et al.The New England Journal of Medicine|May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2016
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 TrialJessica M Fogel, Sarah E Hudelson, San-San Ou, et al.American Heart Journal|June 1, 2020
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillationGanesan Karthikeyan, Stuart J Connolly, Mpiko Ntsekhe, et al.The New England Journal of Medicine|September 3, 2014
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditisBongani M Mayosi, Mpiko Ntsekhe, Jackie Bosch, et al.American Heart Journal|January 29, 2013
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditisBongani M Mayosi, Mpiko Ntsekhe, Jackie Bosch, et al.Pageof 9